Summary
Supporting an Armenian-founded initiative with global reach that is transforming how oncology knowledge, professional expertise and patient perspectives are shared across the world.
Established in 2023, OncoDaily rapidly grew into a leading global oncology platform, connecting oncologists, healthcare professionals, patients, researchers and organizations worldwide. In the past year alone, the platform reached more than 6.7 million active users across over 180 countries, demonstrating the potential of an Armenian-founded initiative to achieve significant global impact.
OncoDaily’s mission is to be the voice of oncology, with a vision to become the fastest, most reliable and innovative global source of oncology information and hence creating a space where professionals, patients and other members of the cancer community can contribute to shaping the future of cancer care.
In 2025, OncoDaily acquired CancerWorld, a long-established European oncology publication, further strengthening its international reach and its role as a platform for knowledge exchange and informed dialogue across the global cancer community.
Building on its success in oncology, OncoDaily is now expanding into other areas of medicine, including hemostasis and fertility. Over the next five years, it aims to extend its model to more than 50 biomedical fields, creating a broader global platform for sharing trusted medical knowledge, professional perspectives and patient voices.
As Her Royal Highness Princess Dina Mired of Jordan has observed: “OncoDaily is a wonderful platform which opened the doors for the whole cancer community to have a space.”
Through its investment in OncoDaily, the Izmirlian Foundation supports an Armenian-founded venture that combines healthcare, innovation and technology with global social impact, while strengthening Armenia’s visibility and contribution to the international medical community.
